Table 1 |
|||||
|
Number of HapMap Phase II SNPs covered ≥ 5 by distance to targeted base |
|||||
|
Distance to |
Number of SNPs (%) |
HapMap |
|||
|
|
|||||
|
targeted base |
M-3 |
M-4 |
A-7 |
T-1 |
Phase II (N) |
|
|
|||||
|
0 bp |
56,648 (91.9) |
56,835 (92.2) |
57,027 (92.5) |
58,142 (94.3) |
61,647 |
|
1 to 200 bp |
50,077 (56.7) |
50,805 (57.5) |
46,144 (52.2) |
57,923 (65.6) |
88,349 |
|
> 200 bp |
13,683 (0.4) |
13,565 (0.4) |
13,987 (0.4) |
17,007 (0.5) |
3,119,167 |
|
Total |
120,408 (3.7) |
121,205 (3.7) |
117,158 (3.6) |
133,072 (4.1) |
3,269,163 |
|
|
|||||
|
The denominator for percentages is the total number of HapMap Phase II SNPs in that distance category. |
|||||
|
Smith et al. Genome Biology 2011 12:R85 doi:10.1186/gb-2011-12-9-r85 |
|||||